TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT05974150: Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Sponsor: Carevive Systems, Inc. · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 25 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$1,524,600

Rescue Site Savings

+$1,016,400

Unlock Full NCT05974150 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05974150 Rescue Dossier →